Nasdaq - Delayed Quote USD

T. Rowe Price Health Sciences Fund (THISX)

91.90 +0.37 (+0.40%)
At close: May 3 at 8:00 PM EDT
Loading Chart for THISX
DELL
  • Previous Close 91.53
  • YTD Return 2.62%
  • Expense Ratio 0.67%
  • Category Health
  • Last Cap Gain 49.00
  • Morningstar Rating
  • Morningstar Risk Rating Above Average
  • Sustainability Rating
  • Net Assets 14.5B
  • Beta (5Y Monthly) 0.76
  • Yield 0.00%
  • 5y Average Return --
  • Holdings Turnover 48.40%
  • Last Dividend 0.14
  • Inception Date Mar 23, 2016

The fund will normally invest at least 80% of its net assets (including any borrowings for investment purposes) in the common stocks of companies engaged in the research, development, production, or distribution of products or services related to health care, medicine, or the life sciences (collectively termed "health sciences"). While the fund can invest in companies of any size, the majority of fund assets are expected to be invested in large- and mid-capitalization companies.

T. Rowe Price

Fund Family

Health

Fund Category

14.5B

Net Assets

2016-03-23

Inception Date

Performance Overview: THISX

Trailing returns as of 5/3/2024. Category is Health.

YTD Return

THISX
2.62%
Category
7.95%
 

1-Year Return

THISX
4.64%
Category
30.16%
 

3-Year Return

THISX
0.29%
Category
16.10%
 

5-Year Return

THISX
9.98%
Category
15.71%
 

People Also Watch

Holdings: THISX

Top 9 Holdings (41.04% of Total Assets)

SymbolCompany% Assets
LLY
Eli Lilly and Company 9.92%
UNH
UnitedHealth Group Incorporated 6.07%
ISRG
Intuitive Surgical, Inc. 4.13%
TMO
Thermo Fisher Scientific Inc. 4.04%
MRK
Merck & Co., Inc. 4.04%
SYK
Stryker Corporation 3.64%
ELV
Elevance Health, Inc. 3.55%
DHR
Danaher Corporation 2.96%
REGN
Regeneron Pharmaceuticals, Inc. 2.69%

Sector Weightings

SectorTHISX
Healthcare   100.00%
Real Estate   0.00%
Technology   0.00%
Utilities   0.00%
Industrials   0.00%
Energy   0.00%

Recent News: THISX

Research Reports: THISX

Top Mutual Funds